In a recent study, Dr. Traci Kazmerski and her team found that early height, but not early weight-for-length/body mass index trajectories, may be associated with pubertal growth outcomes. Cystic fibrosis transmembrane conductance regulator modulator therapy shows the potential to improve pubertal growth outcomes, but further research is necessary.
Read more about their findings here: https://pubmed.ncbi.nlm.nih.gov/37981481/